- CA$3.52m
- CA$67.00m
- CA$71.07m
- 50
- 92
- 21
- 54
Annual balance sheet for Delta 9 Cannabis, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
R2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 5.85 | 8.08 | 4.24 | 3.52 | 2.15 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 6.07 | 5.37 | 5.64 | 2.57 | 2.12 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 24.7 | 32.5 | 34 | 27.2 | 18.2 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 37 | 41.6 | 40.2 | 47.4 | 41 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Total Assets | 62.9 | 76.4 | 78.1 | 89.6 | 74.1 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 11.4 | 15.8 | 43.6 | 52.8 | 46.1 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 31.7 | 44.4 | 53.4 | 83 | 81.4 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 31.1 | 32 | 24.7 | 6.56 | -7.28 |
| Total Liabilities & Shareholders' Equity | 62.9 | 76.4 | 78.1 | 89.6 | 74.1 |
| Total Common Shares Outstanding |